Dizziness is a fairly common ailment. Symptoms among patients range from slight occasional discomfort to complete debilitation due to nausea and vomiting and deterioration of the affected patient's activities of daily living (ADL). Treatment of dizziness varies according to its etiology, but is mostly pharmacological. The authors present a case where Low reactive Level Laser Therapy (LLLT) applied in the Proximal Priority Technique (PPT) was effective in controlling dizziness in a patient suffering from severe spells which occurred several times a week and which caused nausea and vomiting. The authors also retrospectively examine patient records in the Ohshiro Clinic. A total of 11 patients, including the patient in the present case report, report, have been treated for some form of dizziness, and the efficacy of LLLT for the treatment of dizziness is discussed.
Introduction
Dizziness is a fairly common ailment the symptoms of which range from slight occasional discomfort to complete debilitation due to nausea and vomiting, and deterioration of the affected patients' activities of daily living (ADL). Dizziness may be a manifestation of several different etiologies, therefore a careful process to reach a definitive diagnosis is required. Treatment differs according to the etiology but is seldom surgical and mostly pharmacological. For the patients with only slight, occasional spells, careful follow-up with no treatment may be prescribed, whereas others may receive high doses of oral and/or local steroids.
Presently, no reports have appeared in the literature describing the application of low reactive-level laser therapy (LLLT) in alleviating symptoms of dizziness. The authors present the case report of a patient in whom LLLT was extremely effective in alleviating vertigo, where the symptoms were so severe as to cause nausea and vomiting, and preventing the patient from walking. The authors also retrospectively report on a further 10 cases of dizziness treated wiith LLLT, and discuss the efficacy of LLLT.
Subject and Methods
The laser device used was the Oh-Lase 3D1 with the neck irradiator (Japan Medical Laser Laboratory, Tokyo, Japan) which is shown in Fig. 1 . This laser device is based on a GaAlAs diode laser emitting continuous wave light at a wavelength 830 nm in the near infrared, with an incident output power of of 60 mW. This device is unique in that it can emit laser energy through both the neck irradiator probe, which is strapped around the patients' neck and also through the hand held probe. If necessary, a dual channel irradiation through simultaneous emission by both probes is possible and in which case both probes will emit laser light at an output of 60 mW. The patient was treated with this device according to the Proximal Priority Treatment as has been described by Ohshiro (1) . Treatment sessions consist of roughly 5 minutes of treatment to the neck, whereby any tension of the muscles in the region is released, and blood flow to the neck and brain is increased. Another 5 minutes is allotted to treat the shoulder, back and hip region thereby completing the treatment to increase systemic blood flow and preparing the patient for the treatment of each individual ailment, which in the case of this patient was vertigo.
For the treatment of vertigo, direct laser irradiations to the bilateral mastoid processes and external auditory canals, to acupuncture points of the occipital region of the head and peri-orbital regions are performed for a total of ten minutes. Sometimes pressure is applied to the retroauricular region during laser irradiation. The whole treatment session takes roughly 20 minutes and specific laser irradiation times and points are decided on a session-by-session case through observation of the patient's response to laser irradiation. Laser treatment is performed on a weekly basis until initial relief of symptoms is seen, and then the time between treatment sessions may be increased. Continuation of weekly treatments even thereafter is not detrimental in any way, and may be continued if the patient wishes or if the patient feels that the treatment would help him/her.
Case Report
The patient was an 80 year old female, who complained of vertigo spells that had persisted once or twice a month for the previous ten years. This patient presented to the Ohshiro Clinic in August of 2007. She had been diagnosed as having Meniere's disease at another facility over 40 years previously. Sensorineural hearing loss was evident at the time of presentation, but at that time she was still able to converse orally with other people. Difenidol hydrochloride, betahistine mesylate and, adenosine triphosphate disodium, with marginal effect had previously been prescribed. During severe vertigo attacks, she had previously been admitted to the hospital emergency room where she received sodium bicarbonate solution intravenously. Alleviation of her symptoms was, however, slight and temporary at such times.
Following the initial consultation and examination at the Ohshiro Clinic, she was treated with LLLT twice in a one week period using the protocol described above. The treatment sessions proceeded uneventfully. After one week following the second treatment, a family member called in to inform us that the patient was doing well, showing no sign of vertigo spells, and though it has been only two weeks since the initial treatment, they would like to suspend further treatment and observe the course of the patient at home. We concurred with this, understanding that the burden on the family of taking the patient to the clinic on a weekly basis was rather large.
On January, 2008, this same patient returned to the clinic in a wheelchair, accompanied by family members. At this time, the patient had almost complete loss of hearing and conversation was impossible. The family members informed us that ever since the LLLT in August 2007, there were only occasional spells of vertigo, with no spell leading to nausea and vomiting. However, since December 2007, the patient's hearing had deteriorated steadily and vertigo spells, severe enough to cause vomiting, had increased in frequency to once or twice a week. Though each spell in itself was not life threatening, fluid loss and loss of appetite 150
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Fig.1: OhLase -3D1 with the neck irradiator
GaAlAs semi-conductor laser wavelength 830 nm, output 60 mW, continuous wave emission mode Notice that there are two probes: the neck irradiator probe which is strapped to the neck and also the conventional hand held probe. Probes may be used independently or simultaneously had slowly worn the patient down. The patient's family members sought conventional treatment at other facilities, as noted above, but attaining of only temporary relief of symptoms led them to bring the patient back to our clinic. Treatment was recommenced immediately at a rate of once per week. After the 2 nd session, the family members reported that although the vertigo spells still occurred at a weekly basis, there had been no incident of vomiting. After the 3 rd session the frequency of vertigo began to decrease, and by the 6 th session the levels of the patient's ADL of the patient had reverted to normal. With the agreement of the family members, we decided to continue treatment until no vertigo spell was seen for a duration of at least two months while the time between treatments was increased to once a month. By the 8 th visit to the clinic in June of 2008 the criteria had been fulfilled, the patient was treated for the last time and was to be observed at home. The patient returned to the clinic for a follow-up visit in August 2008, at which we confirmed the patient had had no spells of vertigo for the previous 6 months after the third treatment session.
Discussion
Dizziness is a fairly common ailment the symptoms of which can range from slight occasional discomfort to complete debilitation due to nausea and vomiting and deterioration of the patients' ADL. Dizziness may be a manifestation of several different etiologies, therefore a careful process to reach a definitive diagnosis is required. Dizziness could be described as light-headedness, which could be defined as pre-syncope and whose etiology is cardio-vascular in origin. It could be described as a sensation of falling and loss of balance, defined as disequilibrium and the etiology of which is in the in this report, or there may be cases where the diagnosis cannot be reached or where the dizziness is attributed to non-treatable conditions. For patients in such peculiar predicaments, resorting to LLLT is not surprising since LLLT has surprised many in its medical application to even the most obscure and difficult disease states.
At the Ohshiro Clinic, LLLT has been used to treat various conditions since the early 1980's. The records of all patients treated with LLLT at the clinic since 1990 were reviewed, showing that a total of 11 patients (including the present patient) had been treated for dizziness with LLLT during the period from 1992 to 2008 (Table 1) . The individual records of the 11 patients were studied for the therapeutic effect of LLLT for dizziness. The 11 patients consisted of 5 men and 6 women, whose ages ranged from 27 to 80 years old (average age 56.4 years old). The diagnosis of the cause of dizziness was 2 case of sudden sensorineural hearing loss (SSHL), (cases 1 and 2), a single case of post-operative sequela following tympanoplasty for otitis media (case 3), 4 cases of Meniere's disease (cases 4, 8, 9 and11), a single case of post-trauma dizziness (case 6) and 3 cases in whom no definitive diagnosis could be reached and who were classified as suffering from disequilibrium (cases 5, 7 and10). The efficacy of LLLT for dizziness using a 3 grade scale (effective, slightly and or marginally effective, no change) was 45.5% (5/11) effective, 27.3% (3/11) marginally or only slightly effective, and 27.3% (3/11) showing no change. It is interesting to note that 4 of the 5 patients in whom the treatment was effective were diagnosed as having Meniere's disease, including the case presented in this report (case 9). Although no statistical considerations can be performed with the small patient volume and while the citations in the patient records may be biased since no control was been attempted when grading the subjective symptoms of the patients, further research into LLLT for Meniere's disease is warranted and would appear to be promising.
Meniere's disease is a disorder of the inner ear that is characterized by vertigo, tinnitus, with fluctuating, progressive unilateral or bilateral hearing loss, and also a sensation of fullness or pressure in one or both ears. However the symptoms are variable and not all patients suffer the same symptoms. Diagnosis of the disease is usually established through the complaints of the patient and their medical history, and ruling out of brain tumors and superior canal dehiscence by otolaryngological examinations, MRI and/or audiometry. However, the criteria for the clinical diagnosis of this disease are still under debate, although the criteria set in 1995 by The American Academy of Otolarynogology-Head and Neck Surgery Committee on Hearing and Equilibrium ( AAO HNS CHE ) are currently being used (Table 2 ) (2) .
Meniere's disease has been well characterized histopathologically by the presence of endolymphatic hydrops. However, the etiology and pathogenesis of this process are not yet known. Treatment goals for this disease are the alleviation of immediate symptoms such as vertigo, tinnitus and the prevention of recurrence and/or progression of symptoms such as hearing loss. The most conventional of treatments is oral prescription of antihistamines, anticholinergics, steroids and diuretics. It is not known whether the endolym-152 CASE REPORT Fujii Some have asserted that the etiology of Meniere's disease is viral and that it is caused by vestibular ganglionitis from herpes simplex virus infection (4) and have reported that the administration of Acyclovir, an anti-herpes virus drug, has been used with success (5) . Mechanical devices that provide transtympanic micropressure pulses such as the Meniett have been used for treatment and control of vertigo. (6) Other modes of treatment, especially for recalcitrant cases of vertigo, would involve permanent surgical destruction of the affected ear by labyrinthectomy or verstibular nerve section, which results in complete loss of vestibular function of the treated ear and which is always associated with deafness. Craniotomy is required for these surgical procedures which entails complications of its own. A chemical labyrinthectomy using the ototoxicity of aminoglycoside antibiotics, namely gentamicin, has been used where the drug is administered intratympanically. (7) Where and how does LLLT fit in and compare with these treatment methods? LLLT is known, through its photo-bioactivative effects, to alleviate pain and inflammation, and to soften and flatten hypertrophic scars (8) . Such effects are most likely caused by the increase in systemic blood flow and local micro-circulation. Thus LLLT is also used for ambiguous disease entities such as female infertility. Women who are healthy in terms of not having a certain disease but do suffer symptoms such cold and clammy hands and feet, stiff necks and shoulders, can have reduced fecundity. Such symptoms are a manifestation of poor blood flow and treatment of such conditions and increasing the blood flow is thought to enhance hormonal interactions, and response of the ovaries and uterus (9) (10) .
In the case of Meniere's disease, endolymphatic hydrops is thought to be a result of insults to the inner ear through trauma, infections and auto-immune responses. Such damage causes either an over production of endolymphatic fluid or more probably a lowered resorption rate of the fluid, which results in swelling of the endolymphatic sac. Scarring of the tissues of the inner ear is present which may lower the resorption of the fluid. There are at least two possibili-ties on how LLLT alleviates symptoms of Meniere's disease. One is that LLLT may soften the scar tissue within the inner ear resulting in decompression through improvement of the resorption of the endolymphatic fluid. However, from our experience, although LLLT may soften scars to an extent with a single treatment, the effect is usually transient and repeated sessions are necessary. For the cases presented in this report, only two to three treatment sessions were required for the alleviation of symptoms, and while we believe that the scar softening effect of LLLT does play an important role in the long run for the treatment of Meniere's disease, the following possibility is much more feasible. The increase in microcirculation of the endolymphatic sac and surrounding tissue would increase the resorption of the endolymphatic fluid through changes of hydroosmotic pressure. Endolymphatic fluid is constantly produced and absorbed and is evenly balanced in amount in healthy individuals, but is improperly balanced in Meniere's patients. Through increasing the microcirculation of the tissues, LLLT might cause changes in the hydroosmotic pressure between the lumen and surrounding tissue, thereby allowing absorption of the fluid close to normal levels and thus decompressing the swollen endolymphatic sac, resulting in alleviation of vertigo. The rapid response of patients to treatment can be explained with this hypothesis compared to the scar softening effect of LLLT. This also may explain the ineffectiveness of LLLT in other types of dizziness such as disequilibrium, which was seen in elderly patients. These patients had histories of cerebral infarcts which may have caused or affected their balancing ability, and therefore an increase in blood flow or microcirculation would not affect such irreversible central damage. However, this is still in the hypothetical stage and further controlled studies for the clinical effect of LLLT, and basic research concerning the etiology and pathogenesis of Meniere's disease and the therapeutic effect of LLLT for this entity is warranted.
Conclusions
From our experience, LLLT was effective for the treatment of dizziness in 45.5% of the cases treated in our clinic, however the types of dizziness which responded well to LLLT was limited to vertigo associated with Meniere's disease. In the patient from our current report we have confirmed 6 months of complete remission of vertigo following LLLT and believe that LLLT is an excellent option for the treatment of Meniere's disease.
